Prof. Dr. ÖMER UĞUR

Yayın Ağı

Makaleler 62

1. Multimodal imaging analysis of autosomal recessive Parkinson's disease

SOYDAŞ TURAN B., Yalcin-cakmakli G., ERGÜN E., Dasgin H., Karli Oguz K., ELİBOL B., et al.

ANNALS OF NUCLEAR MEDICINE , 2025 (SCI-Expanded, Scopus)

2. Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres

Soydas-Turan B., Bozkurt M. F., Eldem G., PEYNİRCİOĞLU B., UĞUR Ö., VOLKAN SALANCI B.

ANNALS OF NUCLEAR MEDICINE , sa.4, ss.373-379, 2025 (SCI-Expanded, Scopus)

3. Comparison of Dopaminergic and Metabolic Imaging in Monogenic and Idiopathic Parkinson Disease

Turan B. S., Volkan-Salanci B., Ergun E. L., UĞUR Ö., Yalcin-Cakmakli G., Oguz K. K., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.49, sa.SUPPL 1, 2022 (SCI-Expanded, Scopus)

4. Utility of 'dual phase' cone beam computed tomography during radioembolisation in patients with hepatocellular carcinoma: what is really changing in flow dynamics before and after Y-90 delivery?

GÖRMEZ A., ELDEM F. G., VOLKAN SALANCI B., BOZKURT M. F., UĞUR Ö., PEYNİRCİOĞLU B.

POLISH JOURNAL OF RADIOLOGY , cilt.85, 2020 (ESCI, Scopus)

5. The Relation Between Tumor Metabolic Parameters on F-18 FDG PET/CT, Hepatic Artery Perfusion Scan and Therapy Response in Cholangiocellular Carcinoma Treated with Y-90 Microspheres

Bozkurt M., Salanci B. V., Bozkulut U. B., Eldem G., Bozkurt M. F., Kilickap S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.44, 2017 (SCI-Expanded, Scopus)

6. Intra-Arterial Radionuclide Therapies for Liver Tumors

BOZKURT M. F., SALANCI B. V., UĞUR Ö.

SEMINARS IN NUCLEAR MEDICINE , cilt.46, sa.4, ss.324-339, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Intraarterial Yttrium-90 Microsphere Therapy for Primary and Secondary Liver Tumors : A-7-year Experience of a Single Institution.

Bozkurt F., VOLKAN SALANCI B., PEYNİRCİOĞLU B., Eldem G., Cil B., UĞUR Ö.

JOURNAL OF NUCLEAR MEDICINE , cilt.57, 2016 (SCI-Expanded, Scopus)

8. Evaluation of osteoblastic activity in extraction sockets treated with platelet-rich fibrin

BAŞLARLI Ö., Tumer C., UĞUR Ö., Vatankulu B.

MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL , cilt.20, sa.1, 2015 (SCI-Expanded, Scopus)

9. The Relation Between Perfusion Pattern of Hepatic Artery Perfusion Scintigraphy and Response to Y-90 Microsphere Therapy

VOLKAN SALANCI B., BOZKURT M. F., PEYNİRCİOĞLU B., Cil B., UĞUR Ö.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.22, sa.3, ss.98-102, 2013 (ESCI, TRDizin)

10. The Diagnostic Efficiency of Tc-99m-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with In-111-Pentetrotide in the Detection of Neuroendocrine Tumours

Deveci E. K., Ocak M., BOZKURT M. F., Turker S., Kabasakal L., UĞUR Ö.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.22, sa.3, ss.76-84, 2013 (ESCI, TRDizin)

11. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT

Silindir M., Erdoğan S., Özer A. Y., Doğan A. L., Tuncel M., Uğur Ö., et al.

JOURNAL OF LIPOSOME RESEARCH , cilt.23, sa.1, ss.20-27, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Experience with Nuclear Medicine Information System

VOLKAN SALANCI B., Sahin F., Babekoglu V., UĞUR Ö.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.21, sa.3, ss.97-102, 2012 (ESCI, TRDizin)

13. Accelerated progression of metastatic disease shortly after Y90-microsphere treatment: Is there a causative relation?

Bozkurt M., VOLKAN SALANCI B., PEYNİRCİOĞLU B., Cil B., UĞUR Ö.

JOURNAL OF NUCLEAR MEDICINE , cilt.53, 2012 (SCI-Expanded, Scopus)

14. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer

ÇAĞLAR TUNCALI M., Bozkurt F. M., KAPULU AKÇA C. D., Vargol S. E., BAYRAKTAR M., UĞUR Ö., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.33, sa.3, ss.268-274, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Computerized scar detection on renal cortical scintigraphy images

Mumcuoglu E. U., Bozkurt F. M., Aslan M., Sener E., UĞUR Ö.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.32, sa.11, ss.1070-1078, 2011 (SCI-Expanded, Scopus)

16. The Diagnostic Efficiency of Tc-99m-HYNIC-octreotate SPECT-CT in Comparison with In-111-pentetrotide in the Detection of Neuroendocrine Tumours

Deveci E. K., Ocak M., Turker S., Kabasakal L., Ugur O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

17. Can perfusion pattern in pre-therapy hepatic artery perfusion scintigraphy predict radiomicrosphere therapy response?

Volkan-Salanci B., Bozkurt M. F., Cil B., Peynircioglu B., Ugur O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

18. I-123 MIBG SPECT/CT Hybrid Imaging in Evaluation of Neuroectodermal Tumors

Vatankulu B., Bozkurt M. F., Ugur O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

19. Comparative Evaluation of Performance Tests for Two Different Intraoperative Gamma Probes : Proposing Routine Performance Tests Specific to Gamma Probes

Bozkurt M. F., Sar O., Demir G. F., Ugur O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

20. Radioembolization for the treatment of unresectable liver cancer: initial experience at a single center

PEYNİRCİOĞLU B., Cil B., Bozkurt F., Aydemir E., Ugur Ö., BALKANCI F.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.16, sa.1, ss.70-78, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Analysis of Dendritic Cells in Sentinel Lymph Nodes of Patients With Endometrial and Patients With Cervical Cancers

ÖZCAN KARA P. P., AYHAN A., Caner B., GÜLTEKİN M., UĞUR Ö., BOZKURT M. F., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.19, sa.7, ss.1239-1243, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Impact of Image Co-Registration On The Treatment Planning of Y-90 Microsphere Therapy

Bozkurt M. F., Peynircioglu B., Cil B., Kapulu C., Aslan M., Ugur O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.36, 2009 (SCI-Expanded, Scopus)

23. 2009 EANM parathyroid guidelines

Hindie E., Ugur Ö., Fuster D., O'Doherty M., Grassetto G., Urena P., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.36, sa.7, ss.1201-1216, 2009 (SCI-Expanded, Scopus)

24. Value of FDG-PET at 4 weeks after Y-90 resin microsphere therapy for early response evaluation

Bozkurt M., PEYNİRCİOĞLU B., Cil B., UĞUR Ö.

JOURNAL OF NUCLEAR MEDICINE , cilt.50, 2009 (SCI-Expanded, Scopus)

25. Efficacy of Low-Dose I-131 Therapy for the Postoperative Ablation of Low-Risk Differentiated Thyroid Cancer Patients

Caglar M., Bozkurt F., Kapulu C., Ugur O., Bayraktar M.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.35, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Radiosynovectomy: current status in the management of arthritic conditions

Ugur Ö., Gedik G. K., Atilla B., Rubello D.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.29, sa.9, ss.755-758, 2008 (SCI-Expanded, Scopus)

27. The additional diagnostic value of a single-session combined scintigraphic and ultrasonographic examination in patients with thyroid and parathyroid diseases

Gedik G. K., Bozkurt F. M., Ugur Ö., Grassetto G., Rubello D.

PANMINERVA MEDICA , cilt.50, sa.3, ss.199-205, 2008 (SCI-Expanded, Scopus)

28. Sentinel lymph node detection in early stage cervical cancer: a prospective study comparing preoperative lymphoscintigraphy, intraoperative gamma probe, and blue dye

ÖZCAN KARA P. P., AYHAN A., Caner B., Gueltekin M., UĞUR Ö., BOZKURT M. F., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.22, sa.6, ss.487-494, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism

Ugur Ö., Bozkurt M. F., Rubello D.

MINERVA ENDOCRINOLOGICA , cilt.33, sa.2, ss.95-104, 2008 (SCI-Expanded, Scopus)

30. Use of plasma Epstein-Barr virus DNA monitoring as a tumor marker in follow-up of patients with nasopharyngeal carcinoma: Preliminary results and report of two cases

Oezyar E., Gueltekin A., Alp A., Hascelik G., Ugur Ö., Atahan I. L.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS , cilt.22, sa.3, ss.194-199, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake

TUNCEL M., Aydin D., Yaman E., Tazebay U. H., Guc D., Dogan A. L., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.22, sa.3, ss.443-449, 2007 (SCI-Expanded, Scopus)

32. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake

Tuncel M., Aydin D., Yaman E., Tazebay U. H., Guc D., Dogan A. L., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.22, sa.2, ss.281-288, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. A workflow based nuclear medicine information system (NMIS) integrated into HIS and PACS

Ugur O., Sahin F., Kesimli N. B., Duzgunoglu D., Bakir A., Birinci S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded, Scopus)

34. Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy

Gedik G., Ugur Ö., Atilla B., Pekmezci M., Yildirim M., Seven B., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.20, sa.3, ss.183-188, 2006 (SCI-Expanded, Scopus)

35. In vivo characterisation of parathyroid lesions by use of gamma probe: Comparison with ex vivo count method and frozen section results

Ugur Ö., Kara P., Bozkurt M. F., Hamaloglu E., Tezel G., Salanci B., et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY , cilt.134, sa.2, ss.316-320, 2006 (SCI-Expanded, Scopus)

36. Simultaneous surface registration of ictal and interictal SPECT and magnetic resonance images for epilepsy studies

MUMCUOGLU E., NAR F., YARDIMCI Y., KOCAK U., ERGUN E., SALANCI B., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.27, sa.1, ss.45-55, 2006 (SCI-Expanded, Scopus)

37. Losartan renography for the detection of renal artery stenosis: comparison with captopril renography and evaluation of dose and timing

Gunay E., Ozturk M., Ergun E., Altun B., Salanci B., Ugur O., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.32, sa.9, ss.1064-1074, 2005 (SCI-Expanded, Scopus)

38. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.

Ugur O., Bozkurt M. F., Hamaloglu E., Sokmensuer C., Etikan I., Ugur Y., et al.

Archives of surgery (Chicago, Ill. : 1960) , cilt.139, sa.11, ss.1175-9, 2004 (SCI-Expanded, Scopus)

39. Is corticosteroid coinjection necessary for radiosynoviorthesis of patients with hemophilia?

Gedik G., Ugur M., Atilla B., Dundar S.

Clinical Nuclear Medicine , cilt.29, sa.9, ss.538-541, 2004 (SCI-Expanded, Scopus)

40. Optimization of the gamma probe-guided parathyroidectomy

Bozkurt M., Ugur O., Hamaloglu E., Sayek I., Gulec S.

AMERICAN SURGEON , cilt.69, sa.8, ss.720-725, 2003 (SCI-Expanded, Scopus)

41. Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators

Ugur Y., Sari O., Ugur O., Korkusuz P., Varoglu E., Arslan N., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.17, sa.4, ss.281-287, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors

Ugur O., Kothari P., Finn R., Zanzonico P., Ruan S., Guenther I., et al.

NUCLEAR MEDICINE AND BIOLOGY , cilt.29, sa.2, ss.147-157, 2002 (SCI-Expanded, Scopus)

43. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery

Arslan N., Ilgan S., Yuksel D., Serdengecti M., Bulakbasi N., Ugur Ö., et al.

CLINICAL NUCLEAR MEDICINE , cilt.26, sa.8, ss.683-688, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Combined use of bone and bone marrow scintigraphies for the diagnosis of active sacroiliitis: A new approach

Bozkurt M., Ugur Ö., Ertenli I., Caner B.

ANNALS OF NUCLEAR MEDICINE , cilt.15, sa.2, ss.117-121, 2001 (SCI-Expanded, Scopus)

45. Assessment of penile bone graft viability by bone scintigraphy: A case report

Bozkurt M., Ugur O.

ANNALS OF NUCLEAR MEDICINE , cilt.14, sa.5, ss.377-378, 2000 (SCI-Expanded, Scopus)

46. Tc-99m DTPA acetylsalicylic acid (aspirin) renography in the detection of renovascular hypertension

Ergun E., Caglar M., Erdem Y., Usalan C., Ugur O., Duranay M.

CLINICAL NUCLEAR MEDICINE , cilt.25, sa.9, ss.682-690, 2000 (SCI-Expanded, Scopus)

47. Combined use of chemotherapy and I-131-MIBG in the treatment of advanced stage neuroblastoma.

Ugur O., Sari O., Emir S., Akyuz C.

JOURNAL OF NUCLEAR MEDICINE , cilt.41, sa.5, 2000 (SCI-Expanded, Scopus)

48. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy

Yuksel D., Ilgan S., Arslan N., Ugur O., Ozturk E., Bayhan H.

CLINICAL NUCLEAR MEDICINE , cilt.25, sa.3, ss.193-196, 2000 (SCI-Expanded, Scopus)

49. Dobutamine thallium-201 myocardial SPECT in patients with left bundle branch block and normal coronary arteries

Caner B., Rezaghi C., Uysal U., Tokgozoglu L., Kabakci G., Elahi N., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.38, sa.3, ss.424-427, 1997 (SCI-Expanded, Scopus)

50. Hypophosphatemic rickets with sacroiliitis-like presentation in an adolescent

Onur O., Celiker R., Cetin A., Alikasifoglu A., Ugur Ö., Basgoze O.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.26, sa.4, ss.332-335, 1997 (SCI-Expanded, Scopus)

51. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma

Kostakoglu L., Uysal U., ÖZYAR E., Elahi N., Hayran M., Uzal D., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.12, ss.1956-1962, 1996 (SCI-Expanded, Scopus)

52. Comparison of Tc-99m(V)-DMSA, Tl-201 and Tc-99m-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid

Ugur Ö., Kostakoglu L., Guler N., Caner B., Uysal U., Elahi N., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.10, ss.1367-1371, 1996 (SCI-Expanded)

53. Technetium-99m-ethylenedicysteine in the diagnosis and follow-up of renovascular hypertension

UĞUR Ö., Caner B., Çekirge S., BALKANCI F., ERGÜN E., Kostakoǧlu L., et al.

Investigative Radiology , cilt.31, sa.6, ss.378-381, 1996 (Scopus)

54. Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses

Ugur Ö., Kostakoglu L., Hui E., Fisher D., Garmestani K., Gansow O., et al.

NUCLEAR MEDICINE AND BIOLOGY , cilt.23, sa.1, ss.1-8, 1996 (SCI-Expanded)

55. Segmental ATN in a kidney with a single artery transplanted from living related donor

UĞUR Ö., Caner B., Bakkaloǧlu M., ERGÜN E., Toklu C., Ahmadi M., et al.

NuklearMedizin , cilt.35, sa.5, ss.190-192, 1996 (Scopus)

56. The diagnosis of renovascular hypertension with technetium-99m- ethylenedicysteine captopril scintigraphy

UĞUR Ö., Caner B., Çekirge S., BALKANCI F., ERGÜN E., Kostakoǧlu L., et al.

Investigative Radiology , cilt.31, sa.8, ss.497-501, 1996 (Scopus)

57. CALCULATED AND TLD-BASED ABSORBED DOSE ESTIMATES FOR I-131-LABELED 3F8 MONOCLONAL-ANTIBODY IN A HUMAN NEUROBLASTOMA XENOGRAFT NUDE-MOUSE MODEL

UGUR Ö., SCOTT A., KOSTAKOGLU L., HUI T., MASTERSON M., FEBO R., et al.

NUCLEAR MEDICINE AND BIOLOGY , cilt.22, sa.1, ss.87-93, 1995 (SCI-Expanded)

58. IMPAIRED LUNG EPITHELIAL PERMEABILITY IN DIABETICS DETECTED BY TECHNETIUM-99M-DTPA AEROSOL SCINTIGRAPHY

CANER B., UGUR Ö., BAYRAKTAR M., ULUTUNCEL N., MENTES T., TELATAR F., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.35, sa.2, ss.204-206, 1994 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. SCINTIGRAPHIC EVALUATION OF THE SHORT-TERM AND LONG-TERM RENAL EFFECTS OF ORAL FELODIPINE USING TECHNETIUM-99M-MERCAPTOACETYL TRIGLYCINE

OZDEMIR O., ERBAS B., UGUR Ö., VAROGLU E., ERBENGI G., BEKDIK C., et al.

AMERICAN JOURNAL OF NEPHROLOGY , cilt.13, sa.4, ss.249-254, 1993 (SCI-Expanded, Scopus)

60. BLEOMYCIN LUNG TOXICITY DETECTED BY TC-99M DIETHYLENE TRIAMINE PENTA-ACETIC ACID AEROSOL SCINTIGRAPHY

UGUR Ö., CANER B., BALBAY M., OZEN H., REMZI D., ULUTUNCEL N., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.20, sa.2, ss.114-118, 1993 (SCI-Expanded)

61. UTERINE TC-99M MERCAPTOACETYLTRIGLYCINE AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID UPTAKE IN THE SCINTIGRAPHIC EVALUATION OF TRANSPLANTED KIDNEYS

ERBAS B., ARINSOY T., UGUR Ö., VAROGLU E., ARIK N., BEKDIK C.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.19, sa.5, ss.375-377, 1992 (SCI-Expanded)

62. INCREASED ACCUMULATION OF HEXAKIS (2-METHOXYISOBUTYLISONITRILE)TECHNETIUM(I) IN OSTEOSARCOMA AND ITS METASTATIC LYMPH-NODES

CANER B., KITAPCI M., ARAS T., ERBENGI G., UGUR Ö., BEKDIK C.

JOURNAL OF NUCLEAR MEDICINE , cilt.32, sa.10, ss.1977-1978, 1991 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 13

1. Imaging Armamentarium of Hyperparathyroidism; New Player FCH PET-CT-US

TUNCEL M., Kaya G., Caglar M., Kaynaroglu V., CENNET Ö., ÜNLÜTÜRK U., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, (Özet Bildiri)

2. Prognostic Impact of Circulating Angiogenic Factors in 90Y Microsphere Treatment

MAVİ M. E., VOLKAN SALANCI B., LAY İ., ELDEM F. G., PEYNİRCİOĞLU B., YALÇIN Ş., et al.

55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON), Jodhpur, Hindistan, 16 - 19 Kasım 2023, (Özet Bildiri)

3. The relation between tumor metabolic parameters on F-18 FDG PET/CT, hepatic artery perfusion scan and therapy response in cholangiocellular carcinoma treated with Y-90 microspheres

Bozkurt M., VOLKAN SALANCI B., ELDEM F. G., BOZKURT M. F., PEYNİRCİOĞLU B., ÇİL B. E., et al.

EANM congress, Viyana, Avusturya, 21 - 25 Ekim 2017, cilt.44, ss.805, (Özet Bildiri)

4. PET/CT in gastro-esophagial malignancy

UĞUR Ö.

6th Annual Meeting of Kuwait Society of Nuclear Medicine and Molecular Imaging, Kuveyt, 19 - 22 Mart 2017

5. Kolanjiyokarsinom Tanısıyla Karaciğer MetastazlarınaY-90 Mikroküre Tedavisi Verilmiş Hastalarda GörüntülemeYöntemleri ile Tedavi Yanıtının Değerlendirilmesi

bozkurt m., VOLKAN SALANCI B., ELDEM F. G., BOZKURT M. F., PEYNİRCİOĞLU B., ÇİL B. E., et al.

29. ULUSAL NÜKLEER TIP KONGRESİ, Türkiye, 11 - 15 Mayıs 2017, cilt.3, ss.14, (Tam Metin Bildiri)

6. The value of F-18 FDG PET/CT for the early response evaluation of the Y-90 microsphere therapy in colorectal cancer patients with liver metastasis

Volkan-Salanci B., Bozkurt F. M., Peynircioglu B., Cil B., Eldem G., Ugur O.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Gothenburg, İsveç, 18 - 22 Ekim 2014, cilt.41, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Can Radiation Exposure Measurement by GM Counter be Used Interchangeably with Dose Calibrator to Assess the Completeness of Y90-microsphere Therapy?

Bozkurt M. F., Demir G., Salanci B. V., Ugur O.

25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Milan, İtalya, 27 - 31 Ekim 2012, cilt.39, (Özet Bildiri)

8. Comparison of 800MBq and 3700 MBq Iodine-131 for the post-operative ablation of remnant thyroid in patients with differentiated thyroid cancer

Caglar M., Bozkurt F., Akca C. K., Vargol S. E., Ugur O.

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri) Sürdürülebilir Kalkınma